INKT
Mink Therapeutics Inc
NASDAQ: INKT · HEALTHCARE · BIOTECHNOLOGY
$11.81
+8.55% today
Updated 2026-04-29
Market cap
$55.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.93
Dividend yield
—
52W range
$6 – $76
Volume
0.4M
Mink Therapeutics Inc (INKT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.94M | $-8.34M | $-12.83M | $-18.87M | $-15.76M | $-9.56M | $-5.93B |
| Capital expenditures | $426469.00 | $95212.00 | $248983.00 | $250046.00 | $73561.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $219571.00 | $87829.00 | $1.74M | $3.03M | $3.86M | $1.81M | $2.67B |
| Free cash flow | $-15.37M | $-8.43M | $-13.08M | $-19.12M | $-15.84M | $-9.56M | $-5.93B |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-19.27M | — | — | — |